ESC 365 - Audience Q&A - The future is now: impact of oral anticoagulation reversal on your practice.

Open Access

Audience Q&A - The future is now: impact of oral anticoagulation reversal on your practice.

Session: The future is now: impact of oral anticoagulation reversal on your practice

Topic: Acute intensive cardiovascular care

Speaker: Professor G. Lip (Liverpool, GB)

Sponsored by Boehringer Ingelheim

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

100 presentations

9 followers

4 more presentations in this session

The future is now.

Speaker: Professor C. Cannon (Boston, US)

Anticoagulation 3.0: the first NOAC with a reversal agent.

Speaker: Doctor J. Weitz (Hamilton, CA)

Anticoagulation in the electrophysiology lab: how can specific reversal simplify care?

Speaker: Doctor H. Calkins (Baltimore, US)

Anticoagulation post-PCI: case based discussion.

Speaker: Professor S. Hohnloser (Frankfurt, DE)

Access the full session

The future is now: impact of oral anticoagulation reversal on your practice

Speakers: Professor G. Lip, Professor C. Cannon, Doctor J. Weitz, Doctor H. Calkins, Professor S. Hohnloser

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources